CD14 and cancer: Indeed, we show that the inflammatory signature of CXCL-iFibro is functionally relevant, as CXCL-iFibro are able to attract CD14+ monocytes and to polarize them into FOLR2+ macrophages, which have been recently described in cancer and diabetic kidney50–52,54.